MAGEE1: Regulating Insulin Production and Inflammation (G57692)

Target Name: MAGEE1

NCBI ID: G57692

MAGEE1

MAGEE1: Regulating Insulin Production and Inflammation

MAGEE1 (HCA1) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the HCA family of proteins, which are involved in the regulation of various cellular processes, including cell signaling and inflammation.

One of the functions of MAGEE1 is to regulate the production of insulin by the pancreas. Insulin is a hormone that is responsible for regulating blood sugar levels, and it is produced by the pancreas. However, the production of insulin can be impaired in various ways, including by the presence of insulin resistance, which is a condition that makes it difficult for the body to respond to insulin.

MAGEE1 has been shown to play a role in the regulation of insulin production by the pancreas. Studies have shown that MAGEE1 can bind to the insulin receptor on the surface of pancreatic beta cells, which are the cells that produce insulin. This interaction between MAGEE1 and the insulin receptor can cause the beta cells to produce less insulin.

In addition to its role in insulin production, MAGEE1 has also been shown to play a role in the regulation of inflammation. Inflammation is a natural response of the immune system, but chronic inflammation can contribute to a range of diseases, including obesity, type 2 diabetes, and neuroinflammatory disorders.

MAGEE1 has been shown to be involved in the regulation of inflammation by the immune system. Studies have shown that MAGEE1 can interact with the immune system by regulating the production of pro-inflammatory cytokines. These cytokines, which are released by the immune system in response to inflammation, can contribute to the development of chronic inflammation.

MAGEE1 has also been shown to be involved in the regulation of cell signaling. Studies have shown that MAGEE1 can interact with various signaling molecules, including the TGF-beta pathway. This pathway is involved in the regulation of cell growth and differentiation, and it is a key factor in the development of many diseases, including cancer.

In conclusion, MAGEE1 is a protein that is involved in a range of cellular processes that are important for the regulation of insulin production, inflammation, and cell signaling. As a potential drug target, MAGEE1 is an attractive target for the development of new treatments for a variety of diseases.

Protein Name: MAGE Family Member E1

Functions: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex

The "MAGEE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAGEE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets